Sr. Director, Market Access Analytics

The Senior Director, Market Access Analytics as a part of US Insights & Analytics team, will establish and lead CSL Behring's US Payer Analytics capability, building the strategic and analytical foundation required to optimize patient access across the portfolio.

This leader, working closely with Strategic Market Access, Payer Channel Marketing and Market Access Accounts functions, will transform complex payer, claims, and market access data into actionable business insights that influence strategy, improve patient access, and maximize commercial performance. The role requires deep expertise in commercial and government coverage, specialty pharmacy and specialty distributor ecosystems, integrated delivery networks, and the evolving integrated payer landscape within rare and specialty diseases.

This individual will serve as the analytical thought partner to cross-functional partners as well as Senior Leadership.

• Position reports into:
  Executive Director, US Insights & Analytics
• Positions reporting into this position:
  Associate Director, Market Access Analytics; 2X Sr Manager, Market Access Analytics

• Establish the long-term vision, roadmap, and operating model for US Payer Analytics
• Serve as a key member of the US I&A leadership team, ensuring market access insights are integrated with broader commercial insights and priorities.
• Develop scalable analytic capabilities, reporting frameworks, dashboards, and data infrastructure supporting payer decision making
• Build foundational measurement and KPI frameworks for market access performance
• Partner with Data & Analytics teams to improve availability and quality of payer data assets
• Develop comprehensive analytics supporting market access strategy and provide actionable recommendations regarding opportunities and emerging access risks including:
  National and regional coverage assessment, Formulary positioning, Coverage evolution and trends
• Move beyond traditional national reporting by developing detailed analytics at the payer account level. (e.g. Health plan performance, PBM performance, IDN performance, Regional payer performance, etc.)
• Develop a comprehensive reimbursement analytics capability including: PA approval rates, Denial reasons, Appeals submitted, Appeal success rates, Overturn rates, etc.
• Responsibility for oversight and effective management of all team members to include but not limited to the following:
  Annual objective setting, Mid-year and end of year review, Coaching and counseling as appropriate, Employee development
• Stay current with industry benchmarks and best practices to ensure insights and strategies remain competitive and innovative

• Education:
  
  Bachelor's degree required;
  Master's degree (MBA, MS) preferred
• Experience:
  
  15+ years of experience in pharmaceutical, biotechnology, specialty pharmacy, payer, or healthcare analytics
• Experience with in rare disease, specialty biologics, or specialty pharmaceuticals
• Demonstrated success building new analytics capabilities and teams
• Deep understanding of the US payer landscape, including:
  Commercial health plans;
  National and regional PBMs, IDNs, GPOs, SPs, HCOs;
  Strong understanding of reimbursement pathways across both medical and pharmacy benefits;
  Experience with market access data (e.g., MMIT, Fingertip Formulary, IQVIA, Komodo, claims databases) and payer policy analytics
• Proven ability to influence senior executives through data-driven storytelling and strategic recommendations.
• Excellent negotiation, communication, and relationship-building abilities
• Strong Change and Leadership skills
• Different qualifications or responsibilities may apply based on local legal and/or educational requirements. Refer to local job documentation where applicable.

#LI-hybrid

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit  and CSL Plasma at  .

For more information on CSL benefits visit How CSL Supports Your Well-being |